OTHER
Aetiology
Fetal exposure to valproate was associated with lower IQ scores at 3 years of age than exposure to other antiepileptic drugs
| The first 150 words of the full text of this article appear below. |
Is fetal exposure to different antiepileptic drugs associated with different cognitive outcomes in children?
planned interim analysis of a prospective cohort study (Neurodevelopmental Effects of Antiepileptic Drugs [NEAD] study).
25 epilepsy centres in the USA and UK.
309 children, including 6 twins, whose mothers had epilepsy and were taking carbamazepine (n = 93), lamotrigine (n = 100), phenytoin (n = 55), or valproate (n = 61) as monotherapy during pregnancy. Exclusion criteria included maternal IQ scores <70, positive serological tests for syphilis or HIV, progressive cerebral disease, other major disease, exposure to teratogenic agents other than antiepileptic drugs, poor adherence to antiepileptic drugs, or drug abuse in the past year or its sequelae. 258 children (of 252 mothers) were assessed at 2–3 years of age; 309 were included in the analysis.
included type of antiepileptic drug; standardised drug dose; 10 maternal variables including IQ score, age, and preconception use
Bethesda Hospital, Yogyakarta, Indonesia
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
